AAAAAA

   
Results: 1-9 |
Results: 9
ANTITHROMBIN-III IN PATIENTS WITH SEVERE SEPSIS - A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND MULTICENTER TRIAL PLUS A METAANALYSIS ON ALL RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND TRIALS WITH ANTITHROMBIN-III IN SEVERE SEPSIS
Authors: EISELE B LAMY M THIJS LG KEINECKE HO SCHUSTER HP MATTHIAS FR FOURRIER F HEINRICHS H DELVOS U
Citation: B. Eisele et al., ANTITHROMBIN-III IN PATIENTS WITH SEVERE SEPSIS - A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND MULTICENTER TRIAL PLUS A METAANALYSIS ON ALL RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND TRIALS WITH ANTITHROMBIN-III IN SEVERE SEPSIS, Intensive care medicine, 24(7), 1998, pp. 663-672
MICROCIRCULATION AND HEMOSTASIS IN INFLAM MATORY PROCESSES
Authors: LEITHAUSER B MATTHIAS FR
Citation: B. Leithauser et Fr. Matthias, MICROCIRCULATION AND HEMOSTASIS IN INFLAM MATORY PROCESSES, Medizinische Klinik, 92(7), 1997, pp. 426-431
CORONARY RISK-FACTORS IN PATIENTS WITH TE RMINAL RENAL-INSUFFICIENCY
Authors: LUBBECKE F MATTHIAS FR RICHTER U FRETTLOH A KATZ N WIZEMANN V SCHUTTERLE G
Citation: F. Lubbecke et al., CORONARY RISK-FACTORS IN PATIENTS WITH TE RMINAL RENAL-INSUFFICIENCY, Medizinische Klinik, 91(11), 1996, pp. 687-693
HEMOSTATIC ABNORMALITIES AND THE SEVERITY OF ILLNESS IN PATIENTS AT THE ONSET OF CLINICALLY DEFINED SEPSIS - POSSIBLE INDICATION OF THE DEGREE OF ENDOTHELIAL-CELL ACTIVATION
Authors: LEITHAUSER B MATTHIAS FR NICOLAI U VOSS R
Citation: B. Leithauser et al., HEMOSTATIC ABNORMALITIES AND THE SEVERITY OF ILLNESS IN PATIENTS AT THE ONSET OF CLINICALLY DEFINED SEPSIS - POSSIBLE INDICATION OF THE DEGREE OF ENDOTHELIAL-CELL ACTIVATION, Intensive care medicine, 22(7), 1996, pp. 631-636
CORONARY RISK-FACTORS IN CHRONIC HEMODIALYZED PATIENTS
Authors: LUBBECKE F RICHTER U FRETTLOH A MATTHIAS FR KATZ N WIZEMANN V SCHUTTERLE G
Citation: F. Lubbecke et al., CORONARY RISK-FACTORS IN CHRONIC HEMODIALYZED PATIENTS, Kidney international, 47(3), 1995, pp. 988-988
IN-VITRO AND EX-VIVO EFFECTS OF ASPIRIN UPON PLATELETS OF PATIENTS ONA LOW-DOSE ASPIRIN THERAPY
Authors: GEISSLER BS VOSS R MATTHIAS FR
Citation: Bs. Geissler et al., IN-VITRO AND EX-VIVO EFFECTS OF ASPIRIN UPON PLATELETS OF PATIENTS ONA LOW-DOSE ASPIRIN THERAPY, Thrombosis and haemostasis, 69(6), 1993, pp. 632-632
MULTIPLE ORGAN FAILURE - HEMOSTASIS AND MEDIATORS IN SEPTIC PATIENTS
Authors: LEITHAUSER B MATTHIAS FR
Citation: B. Leithauser et Fr. Matthias, MULTIPLE ORGAN FAILURE - HEMOSTASIS AND MEDIATORS IN SEPTIC PATIENTS, Thrombosis and haemostasis, 69(6), 1993, pp. 726-726
HEMOSTATIC PARAMETERS AND MEDIATORS OF INFLAMMATION FOLLOWING PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY OF PERIPHERAL ARTERIES
Authors: FRIEMANN EFJ REITZ D LUEDERS J RAUBER K MATTHIAS FR
Citation: Efj. Friemann et al., HEMOSTATIC PARAMETERS AND MEDIATORS OF INFLAMMATION FOLLOWING PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY OF PERIPHERAL ARTERIES, Thrombosis and haemostasis, 69(6), 1993, pp. 1203-1203
IN-VITRO AND EX-VIVO EFFECTS OF ASPIRIN IN PATIENTS ON A LOW-DOSE ASPIRIN THERAPY
Authors: VOSS R GEISSLER BS TILLMANNS H MATTHIAS FR
Citation: R. Voss et al., IN-VITRO AND EX-VIVO EFFECTS OF ASPIRIN IN PATIENTS ON A LOW-DOSE ASPIRIN THERAPY, Thrombosis research, 72(1), 1993, pp. 49-57
Risultati: 1-9 |